Admin Log in
Rationale, design, and baseline characteristics of a randomized, placebo-controlled cardiovascular outcome trial of empagliflozin (EMPA-REG OUTCOME™).
Lachin, John M
A - Z Index
GW is committed to digital accessibility. If you experience a barrier that affects your ability to access content on this page, let us know via the
Accessibility Feedback Form